Beyond their role in slowing the progression of neurodegenerative diseases by slowing the breakdown of dopamine, MAO-B inhibitors also lower oxidative stress and stimulate the production and release of neurotrophic factors (glial cell line-derived neurotrophic factor) that support dopaminergic neurons [89,90]. This evidence concerns the gene GDNF and neurodegenerative disease.